Share This

Topics Comments

Cheung Kong VODone Limited Shenzhen International Holdings Limited Jiangxi Copper Company Limited REXLot Holdings Limited China Overseas Land & Investment Limited Chong Hing Bank Limited Agricultural Bank of China Limited Chow Tai Fook Jewellery Group Limited Capital VC Limited iShares A50 Standard Chartered Bank of Communications Bank of China China LotSynergy Holdings Limited agribank Agri Airlines Appl AUD Auto A Shares Brokers CAD fertilizer producers China Lottery Supermarket China Banks Communication Consumer China Econ Electricity China Finance China IT Petro Real Est China Resource Steel coal Commodity Beauty Drugs Enviro EURO Lang Simon Ting WongSir Andy Xie Expo Gambling Garment gas GBD Gold Gold Jew Gold mine Harbour Highways HK Apparel REITs Rentals HK Banks ETF HK Housing Market Real Est HK HK Stock iBond Infra Insure IPO jewel Mach Build Mat New Energy NZD Oil Paper Rare Earths Real Estate Market Food RMB Rising RMB RMB Bonds Shipbuilding Shipping Sports Stock Trend Taiwan Dollar (TWD) Textile Top 500 USD US Econ Util Water Yang Liu's 10 Stocks YEN Diary media Central Bank Monetary Policy Education Construction Emerging markets Nuclear power BillGross Cement HK retail logistics Swiss franc Social Security Fund Law Ka-Chung capital flow Financial and political policy Railway film Korean Won Roubini Faber Mobius
Topics Last reply time Nickname Content
ASCLETIS PHARMA INC. 2022-12-21T09:53 財經茄呢啡 歌禮製藥(1672)周一晚宣布旗下口服新冠藥物收到美國專利與商標局(USPTO)的授權公告通知書,公告日期為2023年1月3日。歌禮的口服病毒聚合酶抑制劑ASC10和衍生物可用於治療新冠病毒、猴痘病毒及人呼吸道合胞病毒(RSV)。
ASCLETIS PHARMA INC. 2020-01-30T09:09 財經茄呢啡 媒體報道指,歌禮製藥(1672)產品可用於醫治武漢肺炎,歌禮昨日曾大升54%,高見4.6元;歌禮其後澄清,有關公司旗下產品利托那韋(Ritonavir)及ASC09復方片的報道,是根據中國科學院武漢病毒研究所與軍事醫學科學院毒物研究所聯合研究成果作出,公司並未參與科研過程,亦未提供相關藥物,兩款藥物也未獲得上市批文。歌禮收市仍飆33.22%,報3.97元。
ASCLETIS PHARMA INC. 2018-08-20T09:44 財經茄呢啡 歌禮製藥(1672)是首隻無盈利的生物科技企業,上月招股,超購逾8倍,最終集資接近30億元。歌禮製藥本月1日掛牌上市後,遇上近期藥股捱沽,歌禮上周五收報7.28元,比14元的招股價累跌48%,市值蒸發超過70億元。
ASCLETIS PHARMA INC. 2018-08-20T09:44 財經茄呢啡 歌禮主要研發抗病毒藥物。由於旗下產品未商業化,未有營業收入。公司在2016及2017年度,分別錄得虧損3,187萬元及8,693萬元人民幣。
ASCLETIS PHARMA INC. 2018-08-03T09:02 財經茄呢啡 生物科技股歌禮製藥(1672),首日上市險守招股價14元,昨上市翌日大跌15.3%,收報11.86元,低見11.48元,成交額4.1億元。抽中歌禮新股的投資者若持有至今,一手賬面最多勁蝕2,520元。

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.